DNA Vaccines Market, Global Outlook and Forecast 2023-2029

Report ID: MMG43262 | Category: Pharma & Healthcare | Pages: 76 | Format: PDF | Published Date: February 21,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
This report aims to provide a comprehensive presentation of the global market for DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Vaccines. This report contains market size and forecasts of DNA Vaccines in global, including the following market information:
Global DNA Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global DNA Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five DNA Vaccines companies in 2022 (%)
The global DNA Vaccines market was valued at US$ 4776.4 million in 2022 and is projected to reach US$ 7856.9 million by 2029, at a CAGR of 7.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the DNA Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DNA Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global DNA Vaccines Market Segment Percentages, by Type, 2022 (%)
    Recombinant Protein Vaccine
    Gene-Based Vaccine
Global DNA Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global DNA Vaccines Market Segment Percentages, by Application, 2022 (%)
    Human
    Animal
Global DNA Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global DNA Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies DNA Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies DNA Vaccines revenues share in global market, 2022 (%)
Key companies DNA Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies DNA Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Merck
    GSK
    Sanofi
    Zoties
    Elanco
    Boehringer-Ingelheim
    Indian Immunologicals
    Plumbline Life Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of DNA Vaccines, market overview.
Chapter 2: Global DNA Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global DNA Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 DNA Vaccines Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global DNA Vaccines Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global DNA Vaccines Overall Market Size
    2.1 Global DNA Vaccines Market Size: 2022 VS 2029
    2.2 Global DNA Vaccines Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global DNA Vaccines Sales: 2018-2029
3 Company Landscape
    3.1 Top DNA Vaccines Players in Global Market
    3.2 Top Global DNA Vaccines Companies Ranked by Revenue
    3.3 Global DNA Vaccines Revenue by Companies
    3.4 Global DNA Vaccines Sales by Companies
    3.5 Global DNA Vaccines Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 DNA Vaccines Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers DNA Vaccines Product Type
    3.8 Tier 1, Tier 2 and Tier 3 DNA Vaccines Players in Global Market
        3.8.1 List of Global Tier 1 DNA Vaccines Companies
        3.8.2 List of Global Tier 2 and Tier 3 DNA Vaccines Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global DNA Vaccines Market Size Markets, 2022 & 2029
        4.1.2 Recombinant Protein Vaccine
        4.1.3 Gene-Based Vaccine
    4.2 By Type - Global DNA Vaccines Revenue & Forecasts
        4.2.1 By Type - Global DNA Vaccines Revenue, 2018-2023
        4.2.2 By Type - Global DNA Vaccines Revenue, 2024-2029
        4.2.3 By Type - Global DNA Vaccines Revenue Market Share, 2018-2029
    4.3 By Type - Global DNA Vaccines Sales & Forecasts
        4.3.1 By Type - Global DNA Vaccines Sales, 2018-2023
        4.3.2 By Type - Global DNA Vaccines Sales, 2024-2029
        4.3.3 By Type - Global DNA Vaccines Sales Market Share, 2018-2029
    4.4 By Type - Global DNA Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global DNA Vaccines Market Size, 2022 & 2029
        5.1.2 Human
        5.1.3 Animal
    5.2 By Application - Global DNA Vaccines Revenue & Forecasts
        5.2.1 By Application - Global DNA Vaccines Revenue, 2018-2023
        5.2.2 By Application - Global DNA Vaccines Revenue, 2024-2029
        5.2.3 By Application - Global DNA Vaccines Revenue Market Share, 2018-2029
    5.3 By Application - Global DNA Vaccines Sales & Forecasts
        5.3.1 By Application - Global DNA Vaccines Sales, 2018-2023
        5.3.2 By Application - Global DNA Vaccines Sales, 2024-2029
        5.3.3 By Application - Global DNA Vaccines Sales Market Share, 2018-2029
    5.4 By Application - Global DNA Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global DNA Vaccines Market Size, 2022 & 2029
    6.2 By Region - Global DNA Vaccines Revenue & Forecasts
        6.2.1 By Region - Global DNA Vaccines Revenue, 2018-2023
        6.2.2 By Region - Global DNA Vaccines Revenue, 2024-2029
        6.2.3 By Region - Global DNA Vaccines Revenue Market Share, 2018-2029
    6.3 By Region - Global DNA Vaccines Sales & Forecasts
        6.3.1 By Region - Global DNA Vaccines Sales, 2018-2023
        6.3.2 By Region - Global DNA Vaccines Sales, 2024-2029
        6.3.3 By Region - Global DNA Vaccines Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America DNA Vaccines Revenue, 2018-2029
        6.4.2 By Country - North America DNA Vaccines Sales, 2018-2029
        6.4.3 US DNA Vaccines Market Size, 2018-2029
        6.4.4 Canada DNA Vaccines Market Size, 2018-2029
        6.4.5 Mexico DNA Vaccines Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe DNA Vaccines Revenue, 2018-2029
        6.5.2 By Country - Europe DNA Vaccines Sales, 2018-2029
        6.5.3 Germany DNA Vaccines Market Size, 2018-2029
        6.5.4 France DNA Vaccines Market Size, 2018-2029
        6.5.5 U.K. DNA Vaccines Market Size, 2018-2029
        6.5.6 Italy DNA Vaccines Market Size, 2018-2029
        6.5.7 Russia DNA Vaccines Market Size, 2018-2029
        6.5.8 Nordic Countries DNA Vaccines Market Size, 2018-2029
        6.5.9 Benelux DNA Vaccines Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia DNA Vaccines Revenue, 2018-2029
        6.6.2 By Region - Asia DNA Vaccines Sales, 2018-2029
        6.6.3 China DNA Vaccines Market Size, 2018-2029
        6.6.4 Japan DNA Vaccines Market Size, 2018-2029
        6.6.5 South Korea DNA Vaccines Market Size, 2018-2029
        6.6.6 Southeast Asia DNA Vaccines Market Size, 2018-2029
        6.6.7 India DNA Vaccines Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America DNA Vaccines Revenue, 2018-2029
        6.7.2 By Country - South America DNA Vaccines Sales, 2018-2029
        6.7.3 Brazil DNA Vaccines Market Size, 2018-2029
        6.7.4 Argentina DNA Vaccines Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa DNA Vaccines Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa DNA Vaccines Sales, 2018-2029
        6.8.3 Turkey DNA Vaccines Market Size, 2018-2029
        6.8.4 Israel DNA Vaccines Market Size, 2018-2029
        6.8.5 Saudi Arabia DNA Vaccines Market Size, 2018-2029
        6.8.6 UAE DNA Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Merck
        7.1.1 Merck Company Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck DNA Vaccines Major Product Offerings
        7.1.4 Merck DNA Vaccines Sales and Revenue in Global (2018-2023)
        7.1.5 Merck Key News & Latest Developments
    7.2 GSK
        7.2.1 GSK Company Summary
        7.2.2 GSK Business Overview
        7.2.3 GSK DNA Vaccines Major Product Offerings
        7.2.4 GSK DNA Vaccines Sales and Revenue in Global (2018-2023)
        7.2.5 GSK Key News & Latest Developments
    7.3 Sanofi
        7.3.1 Sanofi Company Summary
        7.3.2 Sanofi Business Overview
        7.3.3 Sanofi DNA Vaccines Major Product Offerings
        7.3.4 Sanofi DNA Vaccines Sales and Revenue in Global (2018-2023)
        7.3.5 Sanofi Key News & Latest Developments
    7.4 Zoties
        7.4.1 Zoties Company Summary
        7.4.2 Zoties Business Overview
        7.4.3 Zoties DNA Vaccines Major Product Offerings
        7.4.4 Zoties DNA Vaccines Sales and Revenue in Global (2018-2023)
        7.4.5 Zoties Key News & Latest Developments
    7.5 Elanco
        7.5.1 Elanco Company Summary
        7.5.2 Elanco Business Overview
        7.5.3 Elanco DNA Vaccines Major Product Offerings
        7.5.4 Elanco DNA Vaccines Sales and Revenue in Global (2018-2023)
        7.5.5 Elanco Key News & Latest Developments
    7.6 Boehringer-Ingelheim
        7.6.1 Boehringer-Ingelheim Company Summary
        7.6.2 Boehringer-Ingelheim Business Overview
        7.6.3 Boehringer-Ingelheim DNA Vaccines Major Product Offerings
        7.6.4 Boehringer-Ingelheim DNA Vaccines Sales and Revenue in Global (2018-2023)
        7.6.5 Boehringer-Ingelheim Key News & Latest Developments
    7.7 Indian Immunologicals
        7.7.1 Indian Immunologicals Company Summary
        7.7.2 Indian Immunologicals Business Overview
        7.7.3 Indian Immunologicals DNA Vaccines Major Product Offerings
        7.7.4 Indian Immunologicals DNA Vaccines Sales and Revenue in Global (2018-2023)
        7.7.5 Indian Immunologicals Key News & Latest Developments
    7.8 Plumbline Life Sciences
        7.8.1 Plumbline Life Sciences Company Summary
        7.8.2 Plumbline Life Sciences Business Overview
        7.8.3 Plumbline Life Sciences DNA Vaccines Major Product Offerings
        7.8.4 Plumbline Life Sciences DNA Vaccines Sales and Revenue in Global (2018-2023)
        7.8.5 Plumbline Life Sciences Key News & Latest Developments
8 Global DNA Vaccines Production Capacity, Analysis
    8.1 Global DNA Vaccines Production Capacity, 2018-2029
    8.2 DNA Vaccines Production Capacity of Key Manufacturers in Global Market
    8.3 Global DNA Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 DNA Vaccines Supply Chain Analysis
    10.1 DNA Vaccines Industry Value Chain
    10.2 DNA Vaccines Upstream Market
    10.3 DNA Vaccines Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 DNA Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

DNA Vaccines Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?